3M announces that it has filed for 510(k) clearance with the Food and Drug Administration (FDA) for an additional patent for its Attest™ Rapid Readout Biological Indicator (BI) System for vaporized hydrogen peroxide sterilization (VH202) to provide BI test results in just 24 minutes. Pending clearance, the 24-minute results will offer the fastest BI readout on the market for VH202 sterilization and make the practice of every load monitoring increasingly feasible.
“Every minute counts when it comes to patient safety,” said Cindy Kent, president and general manager of the 3M Infection Prevention Division. “Central sterile departments deserve simple and effective solutions to help minimize the risk of hospital acquired infections from surgical instruments. Faster BI readout times can increase feasibility to monitor every sterilization load, providing the ultimate confidence that every patient receives safe and sterile equipment.”
A 24-minute delivery would be a significant advancement over 3M’s previous market-leading time of four hours, achieved with the 2016 release of 3M™ Attest™ Rapid Readout Biological Indicator System for VH202. 3M scientists maintained continued focus on software enhancements, following the launch, with the goal of speeding up readout time.
Pending clearance, 3M will have the most comprehensive BI processing portfolio available across all three sterilization modalities commonly used in healthcare facilities worldwide – VH202, steam, and ethylene oxide. Complete and connected sterilization solutions allow department managers to bring consistency to sterilization practices and create a standard release policy. Consistency can also simplify training, reduce workflow errors, and increase compliance with protocols – all of which contribute to increased patient safety.
3M and Attest are trademarks of 3M Company.
Source: 3M
Unmasking Vaccine Myths: Dr Marschall Runge on Measles, Misinformation, and Public Health Solutions
May 29th 2025As measles cases climb across the US, discredited myths continue to undercut public trust in vaccines. In an exclusive interview with Infection Control Today, Michigan Medicine’s Marschall Runge, PhD, confronts misinformation head-on and explores how clinicians can counter it with science, empathy, and community engagement.
Silent Saboteurs: Managing Endotoxins for Sepsis-Free Sterilization
Invisible yet deadly, endotoxins evade traditional sterilization methods, posing significant risks during routine surgeries. Understanding and addressing their threat is critical for patient safety.
Endoscopes and Lumened Instruments: New Studies Highlight Persistent Contamination Risks
May 7th 2025Two new studies reveal troubling contamination in both new endoscopes and cleaned lumened surgical instruments, challenging the reliability of current reprocessing practices and manufacturer guidelines.
From the Derby to the Decontam Room: Leadership Lessons for Sterile Processing
April 27th 2025Elizabeth (Betty) Casey, MSN, RN, CNOR, CRCST, CHL, is the SVP of Operations and Chief Nursing Officer at Surgical Solutions in Overland, Kansas. This SPD leader reframes preparation, unpredictability, and teamwork by comparing surgical services to the Kentucky Derby to reenergize sterile processing professionals and inspire systemic change.